Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States.

ABSTRACT:

Introduction

The impacts of prurigo nodularis (PN) on healthcare resource utilization (HCRU) and associated costs are unclear.

Methods

This retrospective, cross-sectional claims analysis (IQVIA PharMetrics^® Plus) compared HCRU and costs over 1 year in adults with PN versus matched controls (region, payer type, age, sex, year) from 2016 to 2019, and also in patients with PN receiving advanced versus localized/no therapy. For patients with data in multiple calendar years, 1 year was randomly selected. Outcomes were compared by chi-square tests, t tests, or negative binomial tests.

Results

We matched 16,888 patients with PN with 16,888 controls. Most comorbidities (mental health, metabolic conditions, type 2 inflammatory diseases) appeared more frequently in p

SUBMITTER: Kwatra SG 

PROVIDER: S-EPMC11832852 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature